![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
FA Boeckman and E Aizenman
Department of Neurobiology, University of Pittsburgh School of Medicine, Pennsylvania, USA.
The cytotoxicity induced by the transient expression of functional N- methyl-D-aspartate (NMDA) receptors has been examined with the use of a luciferase reporter assay in Chinese hamster ovary cells. Various NMDA receptor antagonists, in a dose-dependent manner, prevented a loss of luciferase activity 24 to 48 hr post-transfection of either the NR1/NR2A or NR1/ NR2B subunit receptor configurations, likely correlating to the time required to express functionally these receptors. Both glutamate and NMDA were potently cytotoxic to transfected cells previously protected by antagonists. The novel ifenprodil analog (1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4- phenylpiperidino)-1-propanol (CP101,606-27) protected cells expressing NR1/NR2B, but not those cells expressing either NR1/NR2A or, putatively, NR1/NR2A/NR2B. Decreased cytotoxicity was observed when a mutated NR1 subunit (N616R) with reduced Ca++ permeability was used in coexpression studies with NR2A or NR2B. In contrast to our results with NR1/NR2A or NR1/NR2B, cells expressing NR1/NR2C did not perish. Our studies suggest that expression of functional NMDA receptors in non- neuronal cells leads to a form of excitotoxicity similar to that observed in mammalian neurons in vitro.
This article has been cited by other articles:
|
|
 |
|
  F. X. Soriano, M.-A. Martel, S. Papadia, A. Vaslin, P. Baxter, C. Rickman, J. Forder, M. Tymianski, R. Duncan, M. Aarts, et al. Specific Targeting of Pro-Death NMDA Receptor Signals with Differing Reliance on the NR2B PDZ Ligand J. Neurosci., October 15, 2008; 28(42): 10696 - 10710. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Floden, S. Li, and C. K. Combs {beta}-Amyloid-Stimulated Microglia Induce Neuron Death via Synergistic Stimulation of Tumor Necrosis Factor {alpha} and NMDA Receptors J. Neurosci., March 9, 2005; 25(10): 2566 - 2575. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Pal, K. A. Hartnett, J. M. Nerbonne, E. S. Levitan, and E. Aizenman Mediation of Neuronal Apoptosis by Kv2.1-Encoded Potassium Channels J. Neurosci., June 15, 2003; 23(12): 4798 - 4802. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Lynch and R. P. Guttmann Excitotoxicity: Perspectives Based on N-Methyl-D-Aspartate Receptor Subtypes J. Pharmacol. Exp. Ther., March 1, 2002; 300(3): 717 - 723. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Sinor, S. Du, S. Venneti, R. C. Blitzblau, D. N. Leszkiewicz, P. A. Rosenberg, and E. Aizenman NMDA and Glutamate Evoke Excitotoxicity at Distinct Cellular Locations in Rat Cortical Neurons In Vitro J. Neurosci., December 1, 2000; 20(23): 8831 - 8837. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Aizenman, J. D. Sinor, J. C. Brimecombe, and G. A. Herin Alterations of N-Methyl-D-aspartate Receptor Properties after Chemical Ischemia J. Pharmacol. Exp. Ther., November 1, 2000; 295(2): 572 - 577. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Li-Smerin, E. Aizenman, and J. W. Johnson Inhibition by Intracellular Mg2+ of Recombinant N-Methyl-D-aspartate Receptors Expressed in Chinese Hamster Ovary Cells J. Pharmacol. Exp. Ther., March 1, 2000; 292(3): 1104 - 1110. [Abstract] [Full Text]
|
|
|
|
|
|
J. C. Brimecombe, W. K. Potthoff, and E. Aizenman A Critical Role of the N-Methyl-D-aspartate (NMDA) Receptor Subunit (NR) 2A in the Expression of Redox Sensitivity of NR1/NR2A Recombinant NMDA Receptors J. Pharmacol. Exp. Ther., November 1, 1999; 291(2): 785 - 792. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. Shao, M. C.-T. Hu, B. P. Zhou, S.-Y. Lin, P. J. Chiao, R. H. von Lindern, B. Spohn, and M.-C. Hung E1A Sensitizes Cells to Tumor Necrosis Factor-induced Apoptosis through Inhibition of Ikappa B Kinases and Nuclear Factor kappa B Activities J. Biol. Chem., July 30, 1999; 274(31): 21495 - 21498. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Arden, J. D. Sinor, W. K. Potthoff, and E. Aizenman Subunit-specific Interactions of Cyanide with the N-Methyl-D-aspartate Receptor J. Biol. Chem., August 21, 1998; 273(34): 21505 - 21511. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Brimecombe, M. J. Gallagher, D. R. Lynch, and E. Aizenman An NR2B Point Mutation Affecting Haloperidol and CP101,606 Sensitivity of Single Recombinant N-Methyl-D-Aspartate Receptors J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 627 - 634. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. C. Brimecombe, F. A. Boeckman, and E. Aizenman Functional consequences of NR2 subunit composition in single recombinant N-methyl-D-aspartate receptors PNAS, September 30, 1997; 94(20): 11019 - 11024. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
